Chembond Biosciences Profile
Key Indicators
- Authorised Capital ₹ 3.00 Cr
as on 16-11-2024
- Paid Up Capital ₹ 1.90 Cr
as on 16-11-2024
- Company Age 13 Year, 5 Months
- Last Filing with ROC 31 Mar 2024
- Revenue -0.84%
(FY 2023)
- Profit -145.53%
(FY 2023)
- Ebitda -271.26%
(FY 2023)
- Net Worth -260.94%
(FY 2023)
- Total Assets -1.21%
(FY 2023)
About Chembond Biosciences
The Corporate was formerly known as Chembond Inver Coatings Limited. The Company is engaged in the Life Sciences Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 3.00 Cr and a paid-up capital of Rs 1.90 Cr, as per Ministry of Corporate Affairs (MCA) records.
Nirmal Shah, Sameer Shah, Rashmi Gavli, and One other member serve as directors at the Company.
- CIN/LLPIN
U36100MH2011PLC219324
- Company No.
219324
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
01 Jul 2011
- Date of AGM
20 Jul 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Thane, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Chembond Biosciences?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sameer Shah  | Managing Director | 01-Jul-2011 | Current |
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Jaywant Tawade | Director | 07-Aug-2021 | Current |
| Nirmal Shah | Director | 01-Jul-2011 | Current |
| Rashmi Gavli | Director | 08-Jun-2018 | Current |
Financial Performance and Corporate Structure Insights of Chembond Biosciences.
Chembond Biosciences Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 0.84% decrease. The company also saw a substantial fall in profitability, with a 145.53% decrease in profit. The company's net worth observed a substantial decline by a decrease of 260.94%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Chembond Biosciences?
In 2023, Chembond Biosciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Phiroze Sethna Private LimitedActive 49 years 5 monthsNirmal Shah, Sameer Shah and 1 more are mutual person
- Chembond Material Technologies Private LimitedActive 24 years 8 months
Nirmal Shah, Sameer Shah and 1 more are mutual person
- Chembond Calvatis Industrial Hygiene Systems LimitedActive 16 years 8 days
Nirmal Shah and Sameer Shah are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Chembond Biosciences?
Chembond Biosciences has a workforce of 54 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Chembond Biosciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Chembond Biosciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
